New Results
Combining CRISPR/Cas9 mutagenesis and a small-molecule inhibitor to probe the function of MELK in cancer
View ORCID ProfileChristopher J. Giuliano, Ann Lin, Joan C. Smith, Ann C. Palladino, View ORCID ProfileJason M. Sheltzer
doi: https://doi.org/10.1101/203984
Christopher J. Giuliano
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
Ann Lin
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
Joan C. Smith
2Google, Inc., New York, New York 10011
Ann C. Palladino
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
Jason M. Sheltzer
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
Article usage
Posted October 16, 2017.
Combining CRISPR/Cas9 mutagenesis and a small-molecule inhibitor to probe the function of MELK in cancer
Christopher J. Giuliano, Ann Lin, Joan C. Smith, Ann C. Palladino, Jason M. Sheltzer
bioRxiv 203984; doi: https://doi.org/10.1101/203984
Subject Area
Subject Areas
- Biochemistry (11730)
- Bioengineering (8743)
- Bioinformatics (29179)
- Biophysics (14964)
- Cancer Biology (12080)
- Cell Biology (17399)
- Clinical Trials (138)
- Developmental Biology (9417)
- Ecology (14174)
- Epidemiology (2067)
- Evolutionary Biology (18294)
- Genetics (12233)
- Genomics (16791)
- Immunology (11858)
- Microbiology (28051)
- Molecular Biology (11575)
- Neuroscience (60919)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4955)
- Plant Biology (10422)
- Synthetic Biology (2881)
- Systems Biology (7338)
- Zoology (1650)